Telemedicine Visit Use and Glycemic Control in Patients With Diabetes
The Journal of Clinical Endocrinology & Metabolism · 2025
DOI: 10.1210/clinem/dgaf177 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2025. Verfasst von Emilia G Thurber und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Endocrinology, Diabetes and Hypertension, Brigham and Women's Hospital, Boston, MA 02115, USA. Hauptthemen laut MEDLINE: Telemedicine, Glycemic Control, COVID-19, Diabetes Mellitus, Type 2. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, NIH HHS, National Institutes of Health.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Context
Endocrinology telemedicine visits increased during the COVID-19 pandemic with unclear impacts on patient outcomes.
Objective
To determine the relationship between different rates and types of telemedicine use and glycemic control in patients with diabetes.
Methods
This was a retrospective cohort study conducted in endocrinology clinics at an integrated health system. Patients were adults with a baseline glycated hemoglobin (HbA1c) measurement in 2020, at least 2 diabetes visits in 2021, and an outcome HbA1c assessment in 2022. The proportion of total visits in 2021 conducted by video or phone was analyzed and the primary outcome was the change in HbA1c between baseline and the 2022 assessment.
Results
The study population (n = 8867) was 51.39% female, with a mean age of 63.90 years and baseline HbA1c of 7.72%. Patients had a mean of 35.09% telemedicine visits in 2021 (25.18% video, 9.91% phone). Between 2020 and 2022, HbA1c decreased by a mean of 0.17%. Multivariable regression analysis adjusted for demographic and clinical covariates demonstrated that higher rates of phone (P = .009) but not video visits were associated with a smaller decrease in HbA1c. When stratified by baseline HbA1c, higher rates of phone visits were associated with a smaller decrease in HbA1c in patients with a baseline HbA1c ≥ 8.0% (P = .001) but not in those with a baseline HbA1c < 8.0%.
Conclusion
Higher rates of phone but not video visits were associated with worse glycemic control in patients with higher baseline HbA1c. Additional research is needed to determine possible causes and strategies for bridging the digital divide.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Endocrinology, Diabetes and Hypertension, Brigham and Women's Hospital, Boston, MA 02115, USA.
- Harvard Medical School, Boston, MA 02115, USA.
ORCID-Profile: Emilia G Thurber, Alexander Turchin
Förderung
- NIDDK NIH HHS
- NIH HHS
- National Institutes of Health
Zitieren
APA
Thurber, E. G., Lan, Z., & Turchin, A. (2025). Telemedicine Visit Use and Glycemic Control in Patients With Diabetes. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgaf177
Vancouver
Thurber EG, Lan Z, Turchin A. Telemedicine Visit Use and Glycemic Control in Patients With Diabetes. The Journal of Clinical Endocrinology & Metabolism. 2025. doi:10.1210/clinem/dgaf177
BibTeX
@article{Thurber2025,
author = {Thurber, Emilia G and Lan, Zhou and Turchin, Alexander},
title = {Telemedicine Visit Use and Glycemic Control in Patients With Diabetes},
journal = {The Journal of Clinical Endocrinology & Metabolism},
year = {2025},
doi = {10.1210/clinem/dgaf177}
}
EUVIMED